GenomeMe

Brand Category: 
Description: 
GenomeMe is an antibody developer and manufacturer with a focus on Precision Diagnostics. GenomeMe's product lines include IHC grade antibodies used as companion diagnostics to detect, characterize, and inform treatment options for cancer patients. GenomeMe is the only company in the world with complete A-Z expertise in antibody development and commercialization. With over 73 hybridoma clones established and commercialized in the past 12 months for diagnostic applications, GenomeMe is fast becoming an industry leader. Our current portfolio includes important diagnostic markers such p16, PD-L1, Her2, IDH1 R132H, and BRAF V600E as well as immunotherapeutic targets such as PD-1, GITR, RORgT, OX-40, OX-40 Ligand, TIM3, CTLA-4, etc. Antibody Catalog: http://www.genomeme.ca/molecular-pathology-catalogs/GenomeMe_Antibody_Catalog_2018.pdf
Country: 
Canada